1. Home
  2. CPRX vs PDCO Comparison

CPRX vs PDCO Comparison

Compare CPRX & PDCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • PDCO
  • Stock Information
  • Founded
  • CPRX 2002
  • PDCO 1877
  • Country
  • CPRX United States
  • PDCO United States
  • Employees
  • CPRX N/A
  • PDCO N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • PDCO Medical Specialities
  • Sector
  • CPRX Health Care
  • PDCO Health Care
  • Exchange
  • CPRX Nasdaq
  • PDCO Nasdaq
  • Market Cap
  • CPRX 2.8B
  • PDCO 2.7B
  • IPO Year
  • CPRX 2006
  • PDCO 1992
  • Fundamental
  • Price
  • CPRX $21.62
  • PDCO $31.07
  • Analyst Decision
  • CPRX Strong Buy
  • PDCO Hold
  • Analyst Count
  • CPRX 8
  • PDCO 10
  • Target Price
  • CPRX $32.25
  • PDCO $27.07
  • AVG Volume (30 Days)
  • CPRX 875.3K
  • PDCO 827.8K
  • Earning Date
  • CPRX 02-26-2025
  • PDCO 03-03-2025
  • Dividend Yield
  • CPRX N/A
  • PDCO 2.51%
  • EPS Growth
  • CPRX 114.68
  • PDCO N/A
  • EPS
  • CPRX 1.18
  • PDCO 1.72
  • Revenue
  • CPRX $460,482,000.00
  • PDCO $6,554,872,000.00
  • Revenue This Year
  • CPRX $24.00
  • PDCO $2.68
  • Revenue Next Year
  • CPRX $15.13
  • PDCO $2.86
  • P/E Ratio
  • CPRX $18.37
  • PDCO $18.02
  • Revenue Growth
  • CPRX 32.17
  • PDCO 0.05
  • 52 Week Low
  • CPRX $13.70
  • PDCO $19.45
  • 52 Week High
  • CPRX $24.64
  • PDCO $31.79
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 40.14
  • PDCO 77.13
  • Support Level
  • CPRX $22.18
  • PDCO $31.01
  • Resistance Level
  • CPRX $23.59
  • PDCO $31.10
  • Average True Range (ATR)
  • CPRX 0.70
  • PDCO 0.04
  • MACD
  • CPRX -0.17
  • PDCO -0.10
  • Stochastic Oscillator
  • CPRX 11.30
  • PDCO 87.50

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About PDCO Patterson Companies Inc.

Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.

Share on Social Networks: